Serum biomarkers that are widely used, including serum alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP), are mainly related to advanced-stage HCC than early-stage disease, and would not be suitable for the diagnosis of early tumors [4,12]. The gene discussed is AFP; the disease is hepatocellular carcinoma.